Infection and infectious diseases

Applied filters

Infection and infectious diseases

Care Setting (1)
- Dentistry (1)
Events (1)
- Past Events (1)
Guidance (48)
- Administering (2)
- Aseptic services (5)
- COVID-19 Treatments (1)
- Cautions and contraindications (2)
- Formulation (2)
- Intrathecal medicines (5)
- Patient Group Directions (30)
- Preparing (2)
- Prescribing (1)
- Procurement (1)
- Safety in Breastfeeding (9)
- Unlicensed medicines (1)
Medicine (46)
- Aciclovir (2)
- Amikacin (1)
- Amoxicillin (2)
- Ampicillin (1)
- Azithromycin (1)
- Benzylpenicillin (2)
- COVID-19 vaccine (1)
- Chloramphenicol (1)
- Clarithromycin (6)
- Co-amoxiclav (2)
- Colistimethate (1)
- Demeclocycline (1)
- Dexamethasone (1)
- Doxycycline (3)
- Erythromycin (6)
- Fidaxomicin (1)
- Flucloxacillin (3)
- Fluorescein (1)
- Fluticasone (1)
- Fusidic acid (1)
- Gentamicin (1)
- Hydrogen peroxide (1)
- Lidocaine (1)
- Malathion (1)
- Metronidazole (2)
- Minocycline (1)
- Mometasone (1)
- Nitrofurantoin (2)
- Oseltamivir (1)
- Oxytetracycline (1)
- Permethrin (1)
- Phenoxymethylpenicillin (3)
- Piperacillin + Tazobactam (1)
- Pivmecillinam (1)
- Sotrovimab (1)
- Temocillin (1)
- Tetracycline (1)
- Tocilizumab (1)
- Trimethoprim (1)
- Valaciclovir (2)
- Vancomycin (2)
- Zanamivir (1)
Publications (30)
- Templates (30)
Specialty (49)
- Eyes and vision (1)
- Infection and infectious diseases (49)
- Neurological disorders (2)
- Renal and urologic disorders (3)
- Respiratory disorders (13)
- Skin disorders (14)

Amikacin: informing intrathecal risk assessment

5 August 2025Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Fluorescein: informing intrathecal risk assessment

8 July 2025Fluorescein products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Choosing between oral vancomycin options

18 June 2025Organisations should choose suitable formulary options for oral vancomycin and mitigate risks. Several factors affect decision making.

Choosing between fidaxomicin options

18 June 2025Organisations should choose suitable fidaxomicin formulary options and mitigate risks. Several factors affect decision making.

Antimicrobial Stewardship (AMS): unlocking the potential

7 March 2023A highly informative mini conference for healthcare teams leading, supporting, and providing oversight of antimicrobial stewardship.

Managing COVID-19 and breastfeeding

1 May 2025Continue breastfeeding during COVID-19 infection, even if dexamethasone, Paxlovid, sotrovimab or tocilzumab are required. COVID-19 vaccines can also be given.

Valaciclovir for shingles

24 April 2025SPS PGD template for supply of valaciclovir for shingles in specified patient groups.

Aciclovir for shingles

24 April 2025SPS PGD template for supply of aciclovir for shingles in specified patient groups.

Flucloxacillin for infected insect bites or stings

27 January 2025SPS PGD template for supply of flucloxacillin for infected insect bites or stings.

Doxycycline for sinusitis

27 January 2025SPS PGD template for the supply of doxycycline for sinusitis in penicillin allergy and where an intranasal steroid is unsuitable or ineffective.